The diaminopimelic acid (DAP) analog, 3-chloro-DAP, was synthesized and tested as the racemic acid for antibacterial activity and for inhibition of DAP epimerase. 3-Chloro-DAP was a potent inhibitor of DAP epimerase purified from Escherichia coli (K, = 200 nM), and it is argued that 3-chloro-DAP is converted to a tight-binding transition state analog at the active site of this enzyme. Furthermore, 3-chloro-DAP inhibited growth of two E. coli mutants. In one of the mutants known for supersusceptibiity to P-lactams, inhibition was not seen until the mid-log phase of growth, while in the other mutant, a DAP auxotroph, inhibition occurred much earlier. Growth inhibition was reversed by DAP in both strains. In the auxotroph, the reversal was specific for meso-DAP, indicating that DAP epimerase was the target for 3-chloro-DAP. Thus we suggest a novel mechanism of bacterial growth inhibition which depends on DAP epimerase inhibition by a DAP analog.
The diaminopimelic acid (DAP) analog, 3-chloro-DAP, was synthesized and tested as the racemic acid for antibacterial activity and for inhibition of DAP epimerase. 3-Chloro-DAP was a potent inhibitor of DAP epimerase purified from Escherichia coli (K, = 200 nM), and it is argued that 3-chloro-DAP is converted to a tight-binding transition state analog at the active site of this enzyme. Furthermore, 3-chloro-DAP inhibited growth of two E. coli mutants. In one of the mutants known for supersusceptibiity to P-lactams, inhibition was not seen until the mid-log phase of growth, while in the other mutant, a DAP auxotroph, inhibition occurred much earlier. Growth inhibition was reversed by DAP in both strains. In the auxotroph, the reversal was specific for meso-DAP, indicating that DAP epimerase was the target for 3-chloro-DAP. Thus we suggest a novel mechanism of bacterial growth inhibition which depends on DAP epimerase inhibition by a DAP analog.
Diaminopimelic acid (DAP) plays an important role in bacterial cell wall rigidity. Cell wall rigidity is maintained by virtue of peptide bond cross-linking between meso-DAP and D-Ala, which are units in tetrapeptide chains attached to N-acetylmuramic acid of the carbohydrate backbone of the peptidoglycan (12) . This function for DAP is found throughout the gram-negative bacterial genera, in certain lactobacilli, and in some Bacillus spp. (10) . Not all DAP residues are involved in cross-linking within the peptidoglycan. Some have free amino groups, while others are bonded to the e-amino group of lysine in the outer membrane lipoprotein (12) . DAP is synthesized within the lysine biosynthetic pathway, where the penultimate step is the synthesis of the meso-DAP from LL-DAP in a reaction catalyzed by 2,6-LLdiaminopimelate 2-epimerase (EC 5.1.1.7) (DAP epimerase).
Several steps in peptidoglycan synthesis have been studied in terms of their inhibition by well-known antibiotics. Inhibition of the synthesis of D-Ala by amino acid analogs such as alaphosphin (2) and cycloserine occurs in the cytoplasm (14) and results in non-cross-linked peptide chains. Likewise, the transpeptidase reaction catalyzed by D-Ala carboxypeptidase is inhibited by penicillin (22) in the cell membrane. Antibiotics with structures related to that of DAP are few in number, and none has therapeutic utility. It has been shown by Chaloupka et al. (5) and Cavalleri et al. (4) that 4-hydroxy-DAP and 3-methyl-DAP, respectively, inhibit the growth of Escherichia coli auxotrophic for DAP. Furthermore, a wild-type E. coli was inhibited by the dipeptide N-(2,6-diamino-6-hydroxymethylpimelyl)-L-Ala, as reported by Shoji et al. (17) . We have discovered that 3-chloro-DAP inhibited growth of an E. coli strain auxotrophic for DAP when the auxotroph was grown in the presence of LL-DAP but not when the auxotroph was grown in the presence of meso-DAP. Furthermore, 3-chloro-DAP was a potent competitive inhibitor of DAP epimerase. We report evidence in this paper that growth inhibition by 3-chloro-DAP correlates with inhibition of DAP epimerase.
MATERIALS AND METHODS

Chemicals.
[3H]DAP (randomly labeled) was purchased from Amersham Corp. 3-Hydroxyand 3-methyl-DAP were the kind gifts of Bruno Cavalleri of Merrell Dow, S.p.A. (Milan, Italy). LL-DAP was isolated from broth culture supernatant of Pseudomonas aeruginosa NCIB 11250 (DAP epimerase deficient) by using the procedure of Saleh and White (16) . The cells were grown at 30°C in the minimal medium of Clarkson and Meadow (6) supplemented with 0.1 mM L-lysine, since DAP auxotrophs often grow poorly in media without lysine supplementation. meso-DAP was separated from a mixture of isomers of DAP obtained from Sigma Chemical Co. The method included several recrystallizations from aqueous ethanol (21) and was shown to be free of LL-DAP by using descending paper chromatography and MeOH-H20-pyridine-HCl (80:17.5:10:7.5) as the solvent.
Bacterial strains and growth media. Merrell Dow strain
Es73 is supersusceptible to P-lactams and was obtained from H. Aoki (1) , whose designation for the strain was Es3l. The E. coli DAP auxotroph (Merrell Dow strain Es85) was obtained from Cavalleri et al. (4) . Strain Es73 was grown at 37°C in Davis minimal medium (7) modified by supplementation with 0.06% acid-hydrolyzed casein and 0.02% yeast extract (CY2 broth). Strain Es85 was grown at 37°C in Davis medium supplemented only with 0.1 mM each of racemic DAP and L-lysine (DMS). Growth inhibition studies. E. coli Es73 was grown for 18 h in CY2 broth and diluted in fresh CY2 broth. E. coli Es85 was grown for 18 h in DMS, centrifuged, washed once, and diluted in Davis medium supplemented only with 0.1 mM L-lysine. The bacterial suspensions were combined with the amino acid additives under study into final volumes of 2 ml. The final cell concentrations were 107 CFU/ml (strain Es73) and 105 CFU/ml (strain Es85). The tubes were incubated at 37°C, and optical densities were monitored at 540 nm with a Bausch & Lomb Spectronic 20 colorimeter.
Enzyme purification and assays. DAP epimerase was purified from E. coli, and DAP dehydrogenase was isolated from Corynebacterium glutamicum as described previously (20) . DAP epimerase was assayed by measuring the rate of release of 3H to water from [3H]DAP. All assays were performed in 0.1 M Tris-1 mM EDTA-1 mM dithiothreitol (pH 7.8, 25°C). Typically, 0.1 ml of reaction mixture containing 0.5 ,uCi of [3H]DAP was acidified with 0.5 ml of 10% trichloroacetic acid and applied to a column (0.5 cm by 2 cm) of AG50W x 4 ion-exchange resin (Bio-Rad Laboratories; 200/400 mesh, H+ form). The column was washed three times, each time with 0.5 ml of water, and the eluates were combined and counted for radioactivity. The DAP epimerase-catalyzed elimination of HCI from 3-chloro-DAP was determined in a coupled reaction system with DAP dehydrogenase. The reaction mixture contained 0.1 mM 3-chloro-DAP, 0.1 mM NADPH, 20 mM NH3, 0.07 U of DAP dehydrogenase per ml, and 0.03 U of DAP epimerase per ml in the pH 7.8 Tris buffer described above. The decrease in A340 was monitored.
Extracellular trichloroacetic acid precipitates. Cells were removed from the culture sample by centrifugation, and spent media were combined with equal volumes of cold 10% trichloroacetic acid. After 1 h on ice, the precipitates were collected by centrifugation and dissolved in 1 ml of 0.1 N NaOH. The A260 and A280 were determined in a Hitachi spectrophotometer, and protein and nucleic acid were calculated by the method of Warburg and Christian (11) .
Synthesis of 3-chloro-DAP. The title compound, 3-chloro-DAP, was synthesized by the sequence depicted in Fig. 1 . Since no effort was expended to separate isomers at any stage of the synthesis, the 3-chloro-DAP prepared was totally racemic. Two syntheses of the key intermediate, 3-hydroxy-DAP, have been published (18, 19) , but neither of them was conveniently amenable to our synthetic goals. Thus, alkylation of the benzylidene Schiff base of ethyl glycinate ( Fig. 1 , compound 1) with 4-bromo-1-butene in tetrahydrofuran (THF) at -78°C with lithium diisopropylamide as the base gave the desired monoalkylated glycinate (compound 2) in 75% yield with dialkylated material (compound 3) as a 15% by-product. Hydrolytic cleavage of the Schiff base (compound 2) followed by reprotection of the free amine with benzoylchloride in the presence of triethylamine in dry CH2Cl2 gave the alkene (compound 4). Ozonolysis (9) of alkene (compound 4) in a 25% MeOH-CH2CI2 solution yielded aldehyde (compound 5) after workup with dimethyl sulfide and pyridine. Alkylation of aldehyde (compound 5) with the benzylidene Schiff base of ethylglycinate (compound 1) with lithium diisopropylamide as the base in anhydrous THF at -78°C proceeded in 65% yield to give alcohol (compound 6). Totally protected alcohol (compound 7) was chlorinated with N-chlorosuccinimide and triphenylphosphine in THF for several hours at room temperature in a 30% yield. Finally, 3-chloro-DAP (compound 9) was prepared by refluxing the tetraprotected precursor (compound 8) in 6 N HCl overnight. Evaporation of the reaction mixture gave the desired product (compound 9) as the dihydrochloride salt.
RESULTS
Effect of 3-chloro-DAP on P-lactam-susceptible E. coli.
Several concentrations of 3-chloro-DAP were tested for growth inhibition of the supersusceptible E. coli. Growth inhibition was related to the concentration of 3-chloro-DAP ( Fig. 2) . At each level of 3-chloro-DAP tested, the growth rate was moderately less than the control rate during the first 4 h of incubation and declined more sharply than the control rate after 4 h. Since 3-chloro-DAP inhibited growth, it seemed reasonable that DAP might reverse the effect of the inhibitor. Thus, 3-chloro-DAP was tried with and without DAP ( versed the inhibitory effect of the analog. This finding was evidence that growth inhibition by 3-chloro-DAP was related to DAP metabolism. After a 6-h incubation (Fig. 3) , samples of growth medium were assayed at 260 and 280 nm for trichloroacetic acid-insoluble macromolecules. Absorbance values from the control supernatant represented 4 ,ug of nucleic acid per ml and 0 ,ug of protein per ml, whereas the 3-chloro-DAP supernatant contained 14 ,ug of nucleic acid per ml and 20 jig of protein per ml. These data show that increased levels of extracellular trichloroacetic acid-insoluble macromolecules were associated with growth inhibition by 3-chloro-DAP.
Effect of 3-chloro-DAP on the DAP auxotroph. The E. coli DAP auxotroph, Es85, required DAP for growth. Either the LL or meso isomer of DAP satisfied the growth requirement ( Table 1 ). The fact that LL-DAP supported growth indicated that Es85 does possess an active DAP epimerase which provided an endogenous source of meso-DAP for the peptidoglycan. Since approximately half-maximal growth was supported by 5 F.M LL-DAP (data not shown), this concentration of LL-DAP was selected for determining an MIC of 3-chloro-DAP. The data in Table 1 (experiment 1) showed an MIC of 3-chloro-DAP of 10 ,uM (2.25 p.g/ml) based on a virtual absence of increased turbidity (A540). Experiment 2a of Table 1 also showed growth inhibition by 10 ,uM 3-chloro-DAP; however, the addition of meso-DAP with (experiment 2b) or without (experiment 2c) LL-DAP alleviated growth inhibition. In both cases, meso-DAP presumably spared the need for DAP epimerase activity. The failure of growth to ensue on 3-chloro-DAP alone (experiment 2e) indicated that the inhibitor did not fulfill the DAP growth requirement of this auxotroph. Inhibition in vitro. 3-Chloro-DAP was found to be a potent inhibitor of purified DAP epimerase from E. coli. The observed inhibition constant was 2 x 10' M, which compares to a Km of 4 x 10-4 M for the substrate LL-DAP. The inhibition was reversible, and full enzymatic activity was recovered after dialysis. The potency of this inhibitor was apparently related to the chloro functionality since 3-hydroxyand 3-methyl-DAP were not as effective ( Table 2) . 3-Chloro-DAP was not a simple competitive inhibitor, however, since the degree of inhibition decreased with time when DAP epimerase was incubated with low concentra-tions of 3-chloro-DAP (data not shown). There was no similar change in the degree of inhibition by the 3-methyl and 3-hydroxy analogs.
The time dependence of the inhibition by 3-chloro-DAP and its dependence on the presence of the epimerase indicated to us that DAP epimerase might be catalyzing the decomposition of the inhibitor. Further, since the inhibitory potency of 3-chloro-DAP seemed dependent on the chloro functionality, the enzyme-catalyzed elimination of HCl was a likely mechanism for decomposition. This elimination reaction would be expected to lead to a succession of products by the series of reactions outlined in Fig. 4 . The ultimate product of the elimination reaction would be expected to be Al-piperidine-2,6-dicarboxylic acid (Fig. 4,   compound 12 ). Conveniently, this cyclic imine has been identified as an intermediate in the biosynthesis of DAP (8) and is a substrate for DAP dehydrogenase (13) . DAP dehydrogenase is part of an alternative pathway for synthesis of DAP which is present primarily in bacteria that use DAP only for the synthesis of lysine. The dehydrogenase catalyzes the reductive amination of the dicarboxylic acid to meso-DAP by NADPH in the presence of NH3. As predicted, when 3-chloro-DAP was incubated with DAP epimerase in the presence of DAP dehydrogenase, NH3, and NADPH, the oxidation of NADPH was observed. The oxidation of NADPH was observed only in the presence of DAP epimerase and is evidence that DAP epimerase catalyzes the elimination of HCl from 3-chloro-DAP to form the piperidine dicarboxylic acid (compound 12). The coupled reaction between DAP epimerase and DAP dehydrogenase was also used to determine the rate of turnover of 3-chloro-DAP by DAP epimerase. The resultant kinetic parameters are given in Table 2 , where they are compared with those for LL-DAP (20) . These results show that 3-chloro-DAP is in fact a poor substrate for DAP epimerase, poor in the sense that the Vmax for the elimination reaction is slow, and the apparent low inhibition constant is in actuality the Km for this substrate. The practical result of these kinetic properties is that 3-chloro-DAP is an effective inhibitor of DAP epimerase. It binds very tightly to this enzyme, with a Km (or apparent Kj) of only 0.2 ,uM; although 3-chloro-DAP is metabolized by DAP epimerase, the rate of turnover is slow enough that the 3-chloro-DAP has a usefully long lifetime in the presence of the enzyme. In bacteria, the ability of 3-chloro-DAP to block the synthesis of meso-DAP will depend on the balance of the rate of uptake of the inhibitor, its rate of turnover, and the metabolic pressure exerted by the build-up of the Al-piperidine-2,6-dicarboxylic acid. ase, we anticipate an inhibition of meso-DAP synthesis to correlate with growth inhibition. Consequently, we further anticipate murein peptides to be deficient in meso-DAP and cross-linking to adjacent peptides and to be less likely to maintain cytoplasmic membrane integrity. This reasoning agrees with the observation of elevated levels of trichloroacetic acid-insoluble macromolecules in the medium taken from cultures exposed to 3-chloro-DAP. Growth inhibition of Es73 cells by 3-chloro-DAP was delayed until the midlogarithmic phase (Fig. 2) . A possible reason for this delay would be the existence of an endogenous pool of DAP which was depleted only after 3 to 4 h of growth. The rescue of Es73 from 3-chloro-DAP by exogenously supplied DAP supports this interpretation. Growth inhibition of the DAP auxotroph by 3-chloro-DAP was manifested differently than that of Es73. Apparently the auxotroph lacks a DAP pool, since it requires exogenous DAP for growth. Thus, following the addition of 3-chloro-DAP the auxotroph, unlike the Es73 strain, did not show an initial period of growth followed by a decline of growth. Rather, inhibition of the auxotroph was complete, since there were no increases in culture density at 10 to 40 puM 3-chloro-DAP. Clearly the product of DAP epimerase (meso-DAP) but not the substrate (LL-DAP) spared the inhibitory action of 3-chloro-DAP, indicating that the inhibitor has the capacity for making cells deficient in meso-DAP, and acts at the level of the epimerase.
DISCUSSION
Our materials and methods used to synthesize 3-chloro-DAP would have theoretically produced four pairs of stereoisomers in approximately equal proportions. Therefore, if only one isomeric pair were active, the true inhibitory concentrations of 3-chloro-DAP would be about 25% of the values reported, e.g., the MIC would be about 0.6 ,ug/ml (Table 1) .
3-Chloro-DAP is a potent inhibitor of DAP epimerase in vitro. The properties of 3-chloro-DAP are unusual, however, since it is not a simple competitive inhibitor. We offer the following explanation for the mechanism of action of 3chloro-DAP in the inhibition of DAP epimerase. It has previously been shown that the mechanism of DAP epimerase is similar to the mechanism of proline racemase (20) . Neither enzyme requires pyridoxal phosphate. Instead, the epimerization reactions for these two enzymes are characterized by proton abstraction on one face with concomitant proton donation on the opposite face as indicated in Fig. 5 (3, 15, 20) . The transition state for this reaction is planar at the epimerized carbon ( Fig. 5 ). Analogs of proline that are planar at C-2, the normal site of epimerization, are transition state analogs and are inhibitors of proline racemase (3) . By analogy, we propose that the elimination of HCl from 3-chloro-DAP results in the formation of a transition state analog that is also planar at C-2 ( Fig. 4, compound 11 ). We speculate that this analog binds tightly to DAP epimerase and is released only slowly from the enzyme, resulting in a very low Km (or apparent K,) and a slow rate of reaction, Vmax, for 3-chloro-DAP. In this respect, therefore, 3-chloro-DAP is a mechanism-based inactivator. It is an innocuous compound by itself but is transformed at the active site of DAP epimerase into a potent competitive inhibitor of that enzyme.
Besides the inhibition of DAP epimerase, other effects on bacterial growth by DAP analogs have been reported. Cavalleri et al. (4) showed that growth of the Es85 auxotroph was inhibited by 3-methyl-DAP, and their proposed mechanism was DAP transport inhibition. Others have shown that DAP analogs were incorporated into peptidoglycan of DAP auxotrophs. Sundharadas and Gilvarg (19) found that one out of four racemic pairs of 3-hydroxy-DAP was incorporated into peptidoglycan and growth ensued. The same strain in the laboratory of Chaloupka et al. (5) incorporated 4hydroxy-DAP into peptidoglycan, but in this case spheroplast formation ensued followed by cell lysis. We did not observe aberrant microscopic morphological forms of E. coli resulting from exposure to 3-chloro-DAP, and there was no evidence in our data that 3-chloro-DAP itself would support growth of either strain Es85 or Es73. Also it is unlikely at the concentrations used that 3-chloro-DAP was acting primarily by blocking uptake of DAP. For example, 3-chloro-DAP inhibited growth of strain Es85 in the presence of LL-DAP but not meso-DAP. In addition, 3-chloro-DAP inhibited growth of strain Es73, which does not require exogenous DAP for growth.
In conclusion, we suggest that 3-chloro-DAP shows a new mechanism for blocking bacterial growth, i.e., the inhibition of the synthesis of meso-DAP, required for cross-linking the peptidoglycan, by inhibition of DAP epimerase.
